Cargando…

Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis

Historically, osteoarticular tuberculosis (TB), including spinal TB, was treated with prolonged course of antitubercular therapy (ATT). Due to various challenges, there has been reluctance to explore the use of short-course ATT in spinal TB. However, with the success of short-course ATT being demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryal, Aayush, Garg, Bhavuk, Mehta, Nishank, Shekhar, Shubhankar, Gupta, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633251/
https://www.ncbi.nlm.nih.gov/pubmed/34784702
http://dx.doi.org/10.31616/asj.2021.0104
_version_ 1784824221286793216
author Aryal, Aayush
Garg, Bhavuk
Mehta, Nishank
Shekhar, Shubhankar
Gupta, Vivek
author_facet Aryal, Aayush
Garg, Bhavuk
Mehta, Nishank
Shekhar, Shubhankar
Gupta, Vivek
author_sort Aryal, Aayush
collection PubMed
description Historically, osteoarticular tuberculosis (TB), including spinal TB, was treated with prolonged course of antitubercular therapy (ATT). Due to various challenges, there has been reluctance to explore the use of short-course ATT in spinal TB. However, with the success of short-course ATT being demonstrated in other forms of extrapulmonary TB, the subject is open for debate again. Therefore, we systematically reviewed various published literature to determine whether short-course treatment regimen (6 months) of ATT provides equivalent results in terms of disease healing as long-course treatment regimen (≥9 months) in the management of spinal TB. Five electronic databases (PubMed, MEDLINE, EMBASE, CENTRAL, and Web of Science) and their reference lists were searched to identify relevant randomized controlled trials with at least 1 year of follow-up that compared short-course with standard-course ATT for treatment of spinal TB. The methodological quality of included studies was assessed, and their data were extracted. A meta-analysis was used to calculate pooled effect sizes and 95% confidence interval (CI). The outcome measure was healed status of the disease at the final follow-up. Of 331 publications identified through literature search, eight publications describing six randomized studies were included. Moreover, 375 of 414 patients (90.58%) who received 6 months of ATT had healed status at their final follow-up compared to 404 of 463 patients (87.26%) who received ≥9 months of ATT. Overall, the healed status of spinal TB was equivalent in patients in both groups (pooled relative risk, 0.98; 95% CI, 0.92–1.04; p=0.439). However, there was considerable heterogeneity among the trials (I2=40.8%, p=0.149). The results suggest that the use of short-course (6 months) chemotherapy may be considered for the treatment of spinal TB in view of the similarity in the healing response achieved compared to treatment regimens of longer duration.
format Online
Article
Text
id pubmed-9633251
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society of Spine Surgery
record_format MEDLINE/PubMed
spelling pubmed-96332512022-11-14 Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis Aryal, Aayush Garg, Bhavuk Mehta, Nishank Shekhar, Shubhankar Gupta, Vivek Asian Spine J Review Article Historically, osteoarticular tuberculosis (TB), including spinal TB, was treated with prolonged course of antitubercular therapy (ATT). Due to various challenges, there has been reluctance to explore the use of short-course ATT in spinal TB. However, with the success of short-course ATT being demonstrated in other forms of extrapulmonary TB, the subject is open for debate again. Therefore, we systematically reviewed various published literature to determine whether short-course treatment regimen (6 months) of ATT provides equivalent results in terms of disease healing as long-course treatment regimen (≥9 months) in the management of spinal TB. Five electronic databases (PubMed, MEDLINE, EMBASE, CENTRAL, and Web of Science) and their reference lists were searched to identify relevant randomized controlled trials with at least 1 year of follow-up that compared short-course with standard-course ATT for treatment of spinal TB. The methodological quality of included studies was assessed, and their data were extracted. A meta-analysis was used to calculate pooled effect sizes and 95% confidence interval (CI). The outcome measure was healed status of the disease at the final follow-up. Of 331 publications identified through literature search, eight publications describing six randomized studies were included. Moreover, 375 of 414 patients (90.58%) who received 6 months of ATT had healed status at their final follow-up compared to 404 of 463 patients (87.26%) who received ≥9 months of ATT. Overall, the healed status of spinal TB was equivalent in patients in both groups (pooled relative risk, 0.98; 95% CI, 0.92–1.04; p=0.439). However, there was considerable heterogeneity among the trials (I2=40.8%, p=0.149). The results suggest that the use of short-course (6 months) chemotherapy may be considered for the treatment of spinal TB in view of the similarity in the healing response achieved compared to treatment regimens of longer duration. Korean Society of Spine Surgery 2022-10 2021-11-18 /pmc/articles/PMC9633251/ /pubmed/34784702 http://dx.doi.org/10.31616/asj.2021.0104 Text en Copyright © 2022 by Korean Society of Spine Surgery https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Aryal, Aayush
Garg, Bhavuk
Mehta, Nishank
Shekhar, Shubhankar
Gupta, Vivek
Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title_full Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title_fullStr Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title_full_unstemmed Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title_short Is 6 Months of Antitubercular Chemotherapy as Effective as More Than 6 Months Regimen in Spinal Tuberculosis? A Systematic Review and Meta-analysis
title_sort is 6 months of antitubercular chemotherapy as effective as more than 6 months regimen in spinal tuberculosis? a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633251/
https://www.ncbi.nlm.nih.gov/pubmed/34784702
http://dx.doi.org/10.31616/asj.2021.0104
work_keys_str_mv AT aryalaayush is6monthsofantitubercularchemotherapyaseffectiveasmorethan6monthsregimeninspinaltuberculosisasystematicreviewandmetaanalysis
AT gargbhavuk is6monthsofantitubercularchemotherapyaseffectiveasmorethan6monthsregimeninspinaltuberculosisasystematicreviewandmetaanalysis
AT mehtanishank is6monthsofantitubercularchemotherapyaseffectiveasmorethan6monthsregimeninspinaltuberculosisasystematicreviewandmetaanalysis
AT shekharshubhankar is6monthsofantitubercularchemotherapyaseffectiveasmorethan6monthsregimeninspinaltuberculosisasystematicreviewandmetaanalysis
AT guptavivek is6monthsofantitubercularchemotherapyaseffectiveasmorethan6monthsregimeninspinaltuberculosisasystematicreviewandmetaanalysis